-
2023
-
Merck Finds Causes of Nitrosamine in Diabetes Drugs
-
NICE Recommends Vutrisiran for Transthyretin-Related Amyloidosis
-
Sun Pharma to Buy Concert Pharma, Gaining Potential Alopecia Areata Treatment
-
National Institutes of Health grant to fund Alzheimer’s research
-
Avidity Biosciences Gets Fast Track for Facioscapulohumeral Muscular Dystrophy
-
FDA Approves Adacel Vaccine During Pregnancy to Protect Infants Against Pertussis
-
Oramed’s oral insulin flunks phase 3 diabetes test, sending stock down 70%
-
FDA Approves Novo Nordisk’s Rybelsus as First Line Treatment for Type 2 Diabetes
-
Hallucination drug could help treat type 2 diabetes
-
Luye claims its first FDA approval, for bi-weekly schizophrenia drug